vasopressin (Human) [8624]
vasopressin (Human)
| SMILES | NC(=O)CC[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC1=O |
| InChIKey | KBZOIRJILGZLEJ-LGYYRGKSSA-N |
| Sequence | CYFQNCPRG |
| HELM | PEPTIDE1{C.Y.F.Q.N.C.P.R.G.[am]}$PEPTIDE1,PEPTIDE1,6:R3-1:R3$$$ |
Chemical Properties
| Hydrogen bond acceptors | 16 |
| Hydrogen bond donors | 14 |
| Rotatable bonds | 19 |
| Log P | -5.404 |
| Molecular weight (Da) | 1083.4 |
| Stereochemistry info | unspecified |
Bioactivities
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Protein | Gene | Species | Family | Class | Type | Min | Avg | Max | Database |
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Protein | Gene | Species | Family | Class | Type | Min | Avg | Max | Database |
vasopressin (Human)
Drug properties
| Molecular type | Peptide |
| Physiological/Surrogate | Endogenous |
| Approved drug | Yes |
Distribution across phases (no. indications)
Phase I
0
Phase II
22
Phase III
16
Phase IV
12
Sankey plot
Drug Information
| Target | Disease | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Gene | Protein | Receptor family | Ligand type | Class | Name | Phase | ICD11 | ATC | Association score |